生物制剂-话题@MedSci

#生物制剂#

123篇内容 | 5350人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1826052, encodeId=2ad31826052af, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, objectType=article, longId=734256, objectId=3e9be342563e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e9be342563e, replyNumber=0, likeNumber=150, createdTime=2022-09-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e9be342563e, moduleTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e9be342563e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826045, encodeId=198b1826045a2, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=类风湿患者如何选择生物制剂？, objectType=article, longId=728773, objectId=7cb2e2877315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cb2e2877315, replyNumber=0, likeNumber=145, createdTime=2022-11-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cb2e2877315, moduleTitle=类风湿患者如何选择生物制剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cb2e2877315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826050, encodeId=df891826050e4, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用, objectType=article, longId=733709, objectId=dab6e337098a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dab6e337098a, replyNumber=0, likeNumber=133, createdTime=2023-01-15, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dab6e337098a, moduleTitle=生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dab6e337098a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826054, encodeId=0bb81826054f4, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=使用生物制剂治疗前的必需筛查, objectType=article, longId=735435, objectId=6ba2e354355b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba2e354355b, replyNumber=0, likeNumber=106, createdTime=2023-01-30, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba2e354355b, moduleTitle=使用生物制剂治疗前的必需筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba2e354355b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2117910, encodeId=f7b2211e910ad, content=<a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a>患者对于<a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>应答反应降低，是因为使用了相关药物，还是疾病本身？抗TNF剂、<a href='/topic/show?id=e827546e83e' target=_blank style='color:#2F92EE;'>#托法替尼#</a>和<a href='/topic/show?id=2ab4e3558a4' target=_blank style='color:#2F92EE;'>#硫嘌呤#</a>，这些具有免疫抑制的功能，当然也可能会包括一些新的<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=J Gastroenterology H : 炎症性肠病患者对于疫苗应答反应降低, objectType=article, longId=761571, objectId=ab8fe6157137, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/abdominal-pain-s2a-photo-of-pain-area-and-internal-abdominal-organs.jpg, objectUrl=/article/show_article.do?id=ab8fe6157137, replyNumber=0, likeNumber=172, createdTime=2023-03-06, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ab8fe6157137, moduleTitle=J Gastroenterology H : 炎症性肠病患者对于疫苗应答反应降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab8fe6157137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826051, encodeId=5b0718260518e, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=儿童活动性狼疮肾炎新选择，美国FDA批准首款儿童生物制剂倍力腾！, objectType=article, longId=734078, objectId=db65e3407891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db65e3407891, replyNumber=0, likeNumber=118, createdTime=2023-06-20, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db65e3407891, moduleTitle=儿童活动性狼疮肾炎新选择，美国FDA批准首款儿童生物制剂倍力腾！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db65e3407891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826041, encodeId=1ec71826041b2, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=炎症细胞因子与生物制剂的关系，为啥生物制剂见效快呢？, objectType=article, longId=301919, objectId=47a6301919eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47a6301919eb, replyNumber=0, likeNumber=160, createdTime=2022-11-15, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47a6301919eb, moduleTitle=炎症细胞因子与生物制剂的关系，为啥生物制剂见效快呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47a6301919eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826062, encodeId=fd2a18260621a, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂DMARDs治疗方案的常见临床问题, objectType=article, longId=738089, objectId=f912e3808982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f912e3808982, replyNumber=0, likeNumber=131, createdTime=2022-11-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f912e3808982, moduleTitle=生物制剂DMARDs治疗方案的常见临床问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f912e3808982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826043, encodeId=08ee182604320, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化, objectType=article, longId=724421, objectId=15afe2442114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15afe2442114, replyNumber=0, likeNumber=127, createdTime=2023-04-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15afe2442114, moduleTitle=CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15afe2442114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826055, encodeId=ee381826055fe, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=从银屑病免疫机制看生物制剂必要性, objectType=article, longId=735437, objectId=b085e3543770, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b085e3543770, replyNumber=0, likeNumber=112, createdTime=2023-03-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b085e3543770, moduleTitle=从银屑病免疫机制看生物制剂必要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b085e3543770)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826047, encodeId=b3cf182604e15, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=AJG:不同生物制剂对克罗恩病患者回肠和结肠内镜愈合的疗效比较, objectType=article, longId=731125, objectId=ea0de3112532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea0de3112532, replyNumber=0, likeNumber=137, createdTime=2022-07-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea0de3112532, moduleTitle=AJG:不同生物制剂对克罗恩病患者回肠和结肠内镜愈合的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea0de3112532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826053, encodeId=287a18260535b, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=孙建方教授：生物制剂时代，传统药物治疗特应性皮炎仍有不可取代的优势, objectType=article, longId=734883, objectId=1c92e34883dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c92e34883dd, replyNumber=0, likeNumber=105, createdTime=2023-07-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c92e34883dd, moduleTitle=孙建方教授：生物制剂时代，传统药物治疗特应性皮炎仍有不可取代的优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c92e34883dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826061, encodeId=80a3182606170, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, objectType=article, longId=737443, objectId=62fae3744324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62fae3744324, replyNumber=0, likeNumber=122, createdTime=2023-04-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62fae3744324, moduleTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62fae3744324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826063, encodeId=54e8182606384, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, objectType=article, longId=738266, objectId=f13fe3826674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f13fe3826674, replyNumber=0, likeNumber=115, createdTime=2022-12-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f13fe3826674, moduleTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f13fe3826674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826056, encodeId=04cb182605666, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, objectType=article, longId=734589, objectId=7cfee34589f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cfee34589f8, replyNumber=0, likeNumber=109, createdTime=2023-06-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cfee34589f8, moduleTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cfee34589f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826058, encodeId=ce6e18260584c, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=华西皮肤论坛（2022）|汪盛教授：难治部位银屑病的生物制剂治疗, objectType=article, longId=735332, objectId=311be35332df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=311be35332df, replyNumber=0, likeNumber=108, createdTime=2023-04-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=311be35332df, moduleTitle=华西皮肤论坛（2022）|汪盛教授：难治部位银屑病的生物制剂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=311be35332df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826049, encodeId=bd9f1826049e8, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用, objectType=article, longId=732948, objectId=b735e32948e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b735e32948e3, replyNumber=0, likeNumber=148, createdTime=2022-10-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b735e32948e3, moduleTitle=生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b735e32948e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826059, encodeId=ce041826059a0, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂停用后复发的原因及对策, objectType=article, longId=735424, objectId=d114e35424a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d114e35424a8, replyNumber=0, likeNumber=116, createdTime=2023-05-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d114e35424a8, moduleTitle=生物制剂停用后复发的原因及对策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d114e35424a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826029, encodeId=66fe1826029c2, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Arthritis Rheumatol：多关节幼年特发性关节炎早期开始使用生物制剂有帮助吗？, objectType=article, longId=218246, objectId=845d2182460d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=845d2182460d, replyNumber=0, likeNumber=59, createdTime=2022-06-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=845d2182460d, moduleTitle=Arthritis Rheumatol：多关节幼年特发性关节炎早期开始使用生物制剂有帮助吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=845d2182460d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826046, encodeId=40e31826046e1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=IJERPH：生物制剂在银屑病治疗中的应用:基于Tuscan管理数据库的药物利用研究, objectType=article, longId=730112, objectId=bd2be30112a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd2be30112a0, replyNumber=0, likeNumber=78, createdTime=2023-05-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd2be30112a0, moduleTitle=IJERPH：生物制剂在银屑病治疗中的应用:基于Tuscan管理数据库的药物利用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd2be30112a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制剂

2020-05-29发表于威斯康星

一叶知秋

#生物制剂#

生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测

2022-09-13

一叶知秋

#生物制剂#

类风湿患者如何选择生物制剂？

2022-11-27

一叶知秋

#生物制剂#

生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用

2023-01-15

一叶知秋

#生物制剂#

使用生物制剂治疗前的必需筛查

2023-01-30

lifestar

#炎症性肠病#患者对于#疫苗#应答反应降低，是因为使用了相关药物，还是疾病本身？抗TNF剂、#托法替尼#和#硫嘌呤#，这些具有免疫抑制的功能，当然也可能会包括一些新的#生物制剂#

J Gastroenterology H : 炎症性肠病患者对于疫苗应答反应降低

2023-03-06发表于上海

一叶知秋

#生物制剂#

儿童活动性狼疮肾炎新选择，美国FDA批准首款儿童生物制剂倍力腾！

2023-06-20

一叶知秋

#生物制剂#

炎症细胞因子与生物制剂的关系，为啥生物制剂见效快呢？

2022-11-15

一叶知秋

#生物制剂#

生物制剂DMARDs治疗方案的常见临床问题

2022-11-13

一叶知秋

#生物制剂#

CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化

2023-04-01

一叶知秋

#生物制剂#

从银屑病免疫机制看生物制剂必要性

2023-03-25

一叶知秋

#生物制剂#

AJG:不同生物制剂对克罗恩病患者回肠和结肠内镜愈合的疗效比较

2022-07-03

一叶知秋

#生物制剂#

孙建方教授：生物制剂时代，传统药物治疗特应性皮炎仍有不可取代的优势

2023-07-14

一叶知秋

#生物制剂#

最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？

2023-04-01

一叶知秋

#生物制剂#

最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？

2022-12-04

一叶知秋

#生物制剂#

生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测

2023-06-02

一叶知秋

#生物制剂#

华西皮肤论坛（2022）|汪盛教授：难治部位银屑病的生物制剂治疗

2023-04-29

一叶知秋

#生物制剂#

生物制剂为什么效果这么好？一文搞懂TA在风湿免疫领域的应用

2022-10-21

一叶知秋

#生物制剂#

生物制剂停用后复发的原因及对策

2023-05-03

一叶知秋

#生物制剂#

Arthritis Rheumatol：多关节幼年特发性关节炎早期开始使用生物制剂有帮助吗？

2022-06-07

一叶知秋

#生物制剂#

IJERPH：生物制剂在银屑病治疗中的应用:基于Tuscan管理数据库的药物利用研究

2023-05-27